Sex differences have been well identified in many brain tumors. Even though glioblastoma
(GBM) is the most common primary malignant brain tumor in adults and has the worst …

Background Radiogenomics is the extension of radiomics through the combination of
genetic and radiomic data. Because genetic testing remains expensive, invasive, and time …

Sex differences in the incidence and outcome of human disease are broadly recognized but,
in most cases, not sufficiently understood to enable sex-specific approaches to treatment …

Over the past few decades, the advent and development of genomic assessment methods
and computational approaches have raised the hopes for identifying therapeutic targets that …

Background We aimed to develop and validate a nomogram combining bi-regional
radiomics features from multimodal magnetic resonance imaging (MRI) and …

Recently, radiogenomics or imaging genomics has emerged as a novel high-throughput
method of associating imaging features with genomic data. Radiogenomics has the potential …

Neuro-oncology largely consists of malignancies of the brain and central nervous system
including both primary as well as metastatic tumors. Currently, a significant clinical …

Background Despite an aggressive therapeutic approach, the prognosis for most patients
with glioblastoma (GBM) remains poor. The aim of this study was to determine the …

Abstract Background and Objective The O 6-methylguanine-DNA-methyltransferase (MGMT)
promoter methylation has been shown to be associated with improved outcomes in patients …

Brain tumor is the growth of abnormal cells in the brain and ranges from noncancerous
(benign) to malignant. Glioblastoma (GBM) is the most aggressive type of brain tumor, rising …